Beranda › Hipersomnia Idiopatik › Ohio
Uji klinis Hipersomnia Idiopatik di Ohio
7 studi untuk Hipersomnia Idiopatik mencari peserta di lokasi di Ohio.
Kota di Ohio
Teks studi resmi (Bahasa Inggris)
A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia
- Takeda Site 2, Cincinnati
- Takeda Site 4, Cincinnati
Menerima pesertaFase 2/3
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07646678A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Neuroscience Research Center, LLC, Canton
- Intrepid Research, Cincinnati
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07500090A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH
- Intrepid Research, Cincinnati
- Ohio Sleep Medicine and Neuroscience Institute, Dublin
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT07625280A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Canton
- Alkermes Investigational Site, Cincinnati
- Alkermes Investigational Site, Cincinnati
- dan 1 lainnya
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06767683A Study of TAK-360 in Adults With Idiopathic Hypersomnia
- Takeda Site 12, Cincinnati
- Takeda Site 17, Cincinnati
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT06812078A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Cleveland, OH, Cleveland
- Dublin, Ohio, Dublin
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT06752668A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Cincinnati, Ohio, Cincinnati
- Dublin, Dublin
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07096674Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.